Loading...
XSHG
600381
Market cap378mUSD
Dec 05, Last price  
4.68CNY
1D
0.00%
1Q
-4.88%
Jan 2017
-69.65%
IPO
-71.74%
Name

Qinghai Spring Medicinl Rsrcs Tech CoLTD

Chart & Performance

D1W1MN
XSHG:600381 chart
P/E
P/S
9.90
EPS
Div Yield, %
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
2.95%
Revenues
270m
+26.36%
585,280,37786,416,7569,602,51840,721,64453,030,61761,371,358238,803,643514,260,5994,167,45829,902,5251,401,689,319708,130,160471,117,193333,018,482233,746,329124,266,266127,764,006160,178,078213,876,676270,264,426
Net income
-199m
L-25.80%
0050,731,273117,046,28951,462,06953,582,58592,611,641032,859,87979,356,632357,575,992244,960,927310,542,22468,446,8595,807,775000-267,865,267-198,766,233
CFO
81m
+238.56%
162,116,15221,566,8446,996,11420,828,46439,161,46071,473,341249,975,574000832,165,160344,988,73495,735,9280000023,916,78080,973,688
Dividend
May 21, 20030.052371 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business. The company was founded in 2003 and is based in Xining, China.
IPO date
May 08, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT